By Daniella Parra Slate Medicines, a private biotech company developing new treatments for migraine and...

By Karen Roman Glucotrack, Inc. (Nasdaq: GCTK) said the US Patent and Trademark Office issued...

By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it expects BiTAC molecules to be...

By Karen Roman CareDx, Inc. (Nasdaq: CDNA) said it completed the acquisition of Naveris, which...

By Karen Roman VERAXA Biotech AG (Nasdaq: VRXA) said it started cell line development for...

By Karen Roman SkylineDx said the FDA granted Breakthrough Device Designation to Merlin CP-GEP, the...

By Karen Roman Imviva Biotech said it has FDA authorization for its Investigational Device Exemption...

By Karen Roman Candel Therapeutics, Inc. (Nasdaq: CADL) said it appointed Mark Sims as Chief...

By Daniella Parra VERAXA Biotech AG (Nasdaq: VRXA)has expanded its R&D facility in Heidelberg, Germany,...

By Karen Roman Prolium Bioscience, Inc. said it dosed its first patient in Phase 1/2...